[FG] Christ Emanuel

Andereggen, L. and Christ, E. (2024) ‘Letter to the Editor from Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study”’, The Journal of Clinical Endocrinology & Metabolism [Preprint]. Available at: https://doi.org/10.1210/clinem/dgae383.

Ebrahimi, Fahim, Andereggen, Lukas and Christ, Emanuel R. (2024) ‘Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management’, Reviews in Endocrine and Metabolic Disorders, 25(3), pp. 599–608. Available at: https://doi.org/10.1007/s11154-024-09888-8.

Beck, Julia et al. (2024) ‘Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms’, Endocrine-Related Cancer, 31. Available at: https://doi.org/10.1530/erc-23-0235.

Fricke, Julia et al. (2024) ‘First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum’, European Journal of Nuclear Medicine and Molecular Imaging [Preprint]. Available at: https://doi.org/10.1007/s00259-024-06641-w.

Hofland, Johannes et al. (2024) ‘Approach to the Patient: Insulinoma’, The Journal of clinical endocrinology and metabolism, 109, pp. 1109–1118. Available at: https://doi.org/10.1210/clinem/dgad641.

Rottenburger, Christof et al. (2024) ‘In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study’, EJNMMI Research, 14. Available at: https://doi.org/10.1186/s13550-024-01101-w.

Rottenburger, Christof et al. (2024) ‘Results of the phase I “Lumed ” study: Dose escalation of 177Lu-PP-F11N in patients with medullary thyroid carcinoma.’, in Annual Congress of the European Association of Nuclear Medicine . Hamburg, Deutschland (Annual Congress of the European Association of Nuclear Medicine ).

Schürrle, Seval Beykan et al. (2024) ‘Dosimetry and pharmacokinetics of [ 177 Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours’, European Journal of Nuclear Medicine and Molecular Imaging [Preprint]. Available at: https://doi.org/10.1007/s00259-024-06682-1.

von Niederhäusern, P.A. et al. (2024) ‘Augmented reality for sentinel lymph node biopsy’, International Journal of Computer Assisted Radiology and Surgery, 19, pp. 171–180. Available at: https://doi.org/10.1007/s11548-023-03014-w.

Christ, E. et al. (2023) ‘Insulinomatosis: new aspects’, Endocrine-Related Cancer, 30(6). Available at: https://doi.org/10.1530/erc-22-0327.

Askari E et al. (2023) ‘Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.’, Journal of nuclear medicine technology, 51(1), pp. 22–25. Available at: https://doi.org/10.2967/jnmt.122.264904.

Kudura K et al. (2023) ‘Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.’, Cancers, 15(5). Available at: https://doi.org/10.3390/cancers15051521.

Fani, Melpomeni and Nicolas, Guillaume P. (2023) ‘⁶¹Cu-labeled radiotracers: Alternative or choice?’, Journal of Nuclear Medicine, 64, pp. 1855–1857. Available at: https://doi.org/10.2967/jnumed.123.266171.

Hemmig, Andrea K. et al. (2023) ‘Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [¹⁸F]FDG Positron Emission Tomography or Ultrasound’, Diagnostics, 13. Available at: https://doi.org/10.3390/diagnostics13233559.

Imperiale, Alessio et al. (2023) ‘The Emergence of Somatostatin Antagonist–Based Theranostics: Paving the Road Toward Another Success?’, Journal of Nuclear Medicine, 64, pp. 682–684. Available at: https://doi.org/10.2967/jnumed.123.265406.

Karnam, Murali et al. (2023) ‘Qualitative and quantitative assessment of admittance controllers for hand-guiding surgical robots’, At-Automatisierungstechnik, 71, pp. 515–527. Available at: https://doi.org/10.1515/auto-2023-0063.

Mallaev, Makhmudbek et al. (2023) ‘3D-Quantitated Single Photon Emission Computed Tomography/Computed Tomography: Impact on intended Management Compared to Lung Perfusion Scan in Marginal Candidates for Pulmonary Resection’, Clinical Lung Cancer, 24(7), pp. 621–630. Available at: https://doi.org/10.1016/j.cllc.2023.07.006.

Maushart, Claudia Irene et al. (2023) ‘Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men’, eBioMedicine, 96. Available at: https://doi.org/10.1016/j.ebiom.2023.104771.

Schmidlin, Moira et al. (2023) ‘Improvement of Lung NET Management through Standardized Care—A Swiss Nationwide Observational Study’, Cancers, 15. Available at: https://doi.org/10.3390/cancers15082270.

Sira, Lívia et al. (2023) ‘Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies’, Frontiers in Endocrinology, 14. Available at: https://doi.org/10.3389/fendo.2023.1095815.

Wild, Damian et al. (2023) ‘A phase I/II study of the safety and efficacy of [ 177 Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours’, European Journal of Nuclear Medicine and Molecular Imaging, 51, pp. 183–195. Available at: https://doi.org/10.1007/s00259-023-06383-1.

Kudura K et al. (2022) ‘Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.’, Cancers, 14(24). Available at: https://doi.org/10.3390/cancers14246095.

Antwi K et al. (2022) ‘Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination.’, Diagnostics (Basel, Switzerland), 12(12). Available at: https://doi.org/10.3390/diagnostics12123073.

Burman P. et al. (2022) ‘Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients’, European Journal of Endocrinology, 187(4), pp. 593–605. Available at: https://doi.org/10.1530/eje-22-0440.

Varum F et al. (2022) ‘Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis.’, International journal of pharmaceutics, 625, p. 122055. Available at: https://doi.org/10.1016/j.ijpharm.2022.122055.

Christ E et al. (2022) ‘Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.’, Swiss medical weekly, 152, p. w30197. Available at: https://doi.org/10.4414/smw.2022.w30197.

Hasegawa S. et al. (2022) ‘Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors’, Cancers, 14(14). Available at: https://doi.org/10.3390/cancers14143317.

Refardt J et al. (2022) ‘Molecular Imaging of Neuroendocrine Neoplasms’, Journal of Clinical Endocrinology and Metabolism, 107(7), pp. E2662–E2670. Available at: https://doi.org/10.1210/clinem/dgac207.

Borbath I et al. (2022) ‘The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.’, European journal of cancer (Oxford, England : 1990), 168, pp. 80–90. Available at: https://doi.org/10.1016/j.ejca.2022.03.007.

Christ E, Wild D and Refardt J (2022) ‘Molecular Imaging in neuroendocrine neoplasias.’, Presse medicale (Paris, France : 1983), 51(2), p. 104115. Available at: https://doi.org/10.1016/j.lpm.2022.104115.

Koehler V.F. et al. (2022) ‘Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series’, Clinical Endocrinology, 96(6), pp. 847–856. Available at: https://doi.org/10.1111/cen.14617.

Freitag MT et al. (2022) ‘Quantitative myocardial perfusion (82)Rb-PET assessed by hybrid PET/coronary-CT: Normal values and diagnostic performance.’, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 29(2), pp. 464–473. Available at: https://doi.org/10.1007/s12350-020-02264-4.

Imfeld S et al. (2022) ‘A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis.’, Diagnostics (Basel, Switzerland), 12(3). Available at: https://doi.org/10.3390/diagnostics12030728.

Hicks RJ et al. (2022) ‘ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.’, Journal of neuroendocrinology, 34(3), p. e13040. Available at: https://doi.org/10.1111/jne.13040.

Hofland J et al. (2022) ‘Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).’, Journal of neuroendocrinology, 34(3), p. e13060. Available at: https://doi.org/10.1111/jne.13060.

Prasad V et al. (2022) ‘Reply: (68)Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication.’, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63(3), pp. 493–494. Available at: https://doi.org/10.2967/jnumed.121.263167.

Huber M. et al. (2022) ‘Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas’, Frontiers in Endocrinology, 13. Available at: https://doi.org/10.3389/fendo.2022.810219.

Boss M et al. (2022) ‘(68)Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism.’, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63(2), pp. 310–315. Available at: https://doi.org/10.2967/jnumed.121.262327.

Ebrahimi, Fahim et al. (2022) ‘Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study’, Frontiers in Endocrinology, 13. Available at: https://doi.org/10.3389/fendo.2022.940990.

Fani, Melpomeni et al. (2022) ‘Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals’, Cancers, 14(5). Available at: https://doi.org/10.3390/cancers14051172.

Fawcett C et al. (2022) ‘Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration.’, Acta cytologica, 66(5), pp. 371–378. Available at: https://doi.org/10.1159/000522662.

Andereggen L. et al. (2021) ‘First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center’, Journal of Endocrinological Investigation, 44(12), pp. 2621–2633. Available at: https://doi.org/10.1007/s40618-021-01569-6.

Andereggen L. et al. (2021) ‘Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-84606-x.

Theiler D. et al. (2021) ‘Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients’, Cancers, 13(24). Available at: https://doi.org/10.3390/cancers13246290.

Walter M.A. et al. (2021) ‘Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis’, Cochrane Database of Systematic Reviews, 2021(11). Available at: https://doi.org/10.1002/14651858.cd013700.pub2.

Hayes AR et al. (2021) ‘Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.’, The Journal of clinical endocrinology and metabolism, 106(12), pp. e4903–e4916. Available at: https://doi.org/10.1210/clinem/dgab588.

von Guggenberg E et al. (2021) ‘Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals.’, Cancers, 13(22). Available at: https://doi.org/10.3390/cancers13225776.

Refardt J et al. (2021) ‘New Directions in Imaging Neuroendocrine Neoplasms.’, Current oncology reports, 23(12), p. 143. Available at: https://doi.org/10.1007/s11912-021-01139-2.

Andereggen L. et al. (2021) ‘Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort’, Acta Neurochirurgica, 163(11), pp. 3161–3169. Available at: https://doi.org/10.1007/s00701-021-04830-2.

Berkmann S et al. (2021) ‘Prevalence and outcome of comorbidities associated with acromegaly’, Acta Neurochirurgica, 163(11), pp. 3171–3180. Available at: https://doi.org/10.1007/s00701-021-04846-8.

Gut L et al. (2021) ‘Sex-Specific Differences in Outcomes Following Thyroidectomy: A Population-Based Cohort Study.’, European thyroid journal, 10(6), pp. 476–485. Available at: https://doi.org/10.1159/000510618.

Kobayashi N et al. (2021) ‘Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors.’, Journal of hepato-biliary-pancreatic sciences, 28(9), pp. 727–739. Available at: https://doi.org/10.1002/jhbp.1014.

Refardt J et al. (2021) ‘Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.’, Reviews in endocrine & metabolic disorders, 22(3), pp. 581–594. Available at: https://doi.org/10.1007/s11154-020-09552-x.

Andereggen L et al. (2021) ‘Letter to the Editor From Lukas Andereggen: ‘Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review’.’, 106(8). Available at: https://doi.org/10.1210/clinem/dgab329.

Wild D et al. (2021) ‘Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?’, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(Suppl 2), pp. 44S–50S. Available at: https://doi.org/10.2967/jnumed.120.246009.

Braun M et al. (2021) ‘Accuracy comparison of various quantitative [(99m)Tc]Tc-DPD SPECT/CT reconstruction techniques in patients with symptomatic hip and knee joint prostheses.’, EJNMMI research, 11(1), p. 60. Available at: https://doi.org/10.1186/s13550-021-00794-7.

Andereggen L, Frey J and Christ E (2021) ‘Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.’, Endocrine, 72(1), pp. 216–222. Available at: https://doi.org/10.1007/s12020-020-02557-1.

Ambrosini V et al. (2021) ‘Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.’, European journal of cancer (Oxford, England : 1990), 146, pp. 56–73. Available at: https://doi.org/10.1016/j.ejca.2021.01.008.

Andereggen L. et al. (2021) ‘Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term’, Journal of Clinical and Translational Endocrinology, 24. Available at: https://doi.org/10.1016/j.jcte.2021.100258.

Andereggen L et al. (2021) ‘Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing’s syndrome.’, Journal of neuroradiology = Journal de neuroradiologie, 48(1), pp. 10–15. Available at: https://doi.org/10.1016/j.neurad.2019.05.004.

Andereggen L and Christ E (2021) ‘Commentary: ‘Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery’.’, 12. Available at: https://doi.org/10.3389/fendo.2021.695498.

Antwi K et al. (2021) ‘Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.’, PloS one, 16(6), p. e0253078. Available at: https://doi.org/10.1371/journal.pone.0253078.

Ebrahimi F. et al. (2021) ‘Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome’, Scientific Reports, 11. Available at: https://doi.org/10.1038/s41598-021-87207-w.

Hess, Gabriel Fridolin et al. (2021) ‘Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach’, Case Reports in Surgery, 2021(8811155). Available at: https://doi.org/10.1155/2021/8811155.

Mueller M. et al. (2021) ‘Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism’, Endocrine Connections, 10, pp. 1273–1282. Available at: https://doi.org/10.1530/ec-21-0363.

Preisig, Daniel et al. (2021) ‘Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: a clinical pharmacoscintigraphy study’, European Journal of Pharmaceutics and Biopharmaceutics, 165, pp. 22–30. Available at: https://doi.org/10.1016/j.ejpb.2021.05.002.

Rottenburger, Christof et al. (2021) ‘¹⁸F-FDG PET/CT compared with ultrasound and biopsy for detection of vasculitis of the temporal artery branches’, Swiss Medical Weekly, 151. Available at: https://doi.org/10.4414/smw.2021.20512.

Martel-Duguech LM et al. (2020) ‘ESE audit on management of Adult Growth Hormone Deficiency in clinical practice.’, European journal of endocrinology [Preprint]. Available at: https://doi.org/10.1530/eje-20-1180.

Schaerli N et al. (2020) ‘Incremental value of high-frequency QRS analysis for diagnosis and prognosis in suspected exercise-induced myocardial ischaemia.’, European heart journal. Acute cardiovascular care, 9(8), pp. 836–847. Available at: https://doi.org/10.1177/2048872619842988.

Ebrahimi F et al. (2020) ‘Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.’, The Journal of clinical endocrinology and metabolism, 105(11). Available at: https://doi.org/10.1210/clinem/dgaa517.

Refardt J et al. (2020) ‘Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging.’, Endocrine-related cancer, 27(11), pp. 615–624. Available at: https://doi.org/10.1530/erc-20-0340.

Rottenburger C and Lutz T (2020) ‘[The ablative radioiodine therapy of differentiated thyroid carcinoma].’, Therapeutische Umschau. Revue therapeutique, 77(9), pp. 427–431. Available at: https://doi.org/10.1024/0040-5930/a001214.

Caobelli F et al. (2020) ‘Quantitative (99m)Tc-DPD SPECT/CT in patients with suspected ATTR cardiac amyloidosis: Feasibility and correlation with visual scores.’, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 27(5), pp. 1456–1463. Available at: https://doi.org/10.1007/s12350-019-01893-8.

Mansi R et al. (2020) ‘Evaluation of a New (177)Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5.’, Molecules (Basel, Switzerland), 25(18). Available at: https://doi.org/10.3390/molecules25184155.

Antwi K et al. (2020) ‘Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging.’, Clinical nuclear medicine, 45(9), pp. e386–e392. Available at: https://doi.org/10.1097/rlu.0000000000003124.

Häfliger S et al. (2020) ‘Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor.’, 13(3). Available at: https://doi.org/10.1159/000510334.

Walter M.A. et al. (2020) ‘Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis’, Cochrane Database of Systematic Reviews, 2020(8). Available at: https://doi.org/10.1002/14651858.cd013700.

Mansi R et al. (2020) ‘A new (68)Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting.’, EJNMMI research, 10(1), p. 90. Available at: https://doi.org/10.1186/s13550-020-00677-3.

Fischer JGW et al. (2020) ‘Comparison of [(18)F]FDG PET/CT with magnetic resonance imaging for the assessment of human brown adipose tissue activity.’, EJNMMI research, 10(1), p. 85. Available at: https://doi.org/10.1186/s13550-020-00665-7.

Schunemann M.J. et al. (2020) ‘Wither Away: Weight Loss and Persistent Inflammation in a Woman With Whipple Disease’, American Journal of Medicine, 133(6), pp. e223–e226. Available at: https://doi.org/10.1016/j.amjmed.2019.08.058.

Merola E et al. (2020) ‘Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?’, Annals of surgical oncology, 27(5), pp. 1348–1355. Available at: https://doi.org/10.1245/s10434-019-08049-5.

Christ E et al. (2020) ‘Innovative imaging of insulinoma: the end of sampling? A review.’, Endocrine-related cancer, 27(4), pp. R79–R92. Available at: https://doi.org/10.1530/erc-19-0476.

Imfeld S et al. (2020) ‘[18F]FDG positron emission tomography and ultrasound in the diagnosis of giant cell arteritis: congruent or complementary imaging methods?’, Rheumatology (Oxford, England), 59(4), pp. 772–778. Available at: https://doi.org/10.1093/rheumatology/kez362.

Rottenburger C et al. (2020) ‘Cholecystokinin 2 Receptor Agonist (177)Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study.’, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 61(4), pp. 520–526. Available at: https://doi.org/10.2967/jnumed.119.233031.

Maas O et al. (2020) ‘Variations in radioiodine ablation: decision-making after total thyroidectomy.’, European journal of nuclear medicine and molecular imaging, 47(3), pp. 554–560. Available at: https://doi.org/10.1007/s00259-019-04557-4.

Coto-Llerena, Mairene et al. (2020) ‘High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes’, Frontiers in Oncology, 10, p. 979. Available at: https://doi.org/10.3389/fonc.2020.00979.

Fuchs, Philipp S. et al. (2020) ‘Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients’, Frontiers in Immunology, 11(11), p. 613130. Available at: https://doi.org/10.3389/fimmu.2020.613130.

Hepprich M et al. (2020) ‘Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging.’, 2020. Available at: https://doi.org/10.1155/2020/4510910.

Reto M Kaderli et al. (2020) ‘Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis’, JAMA Oncology [Preprint].

Antwi K et al. (2019) ‘68Ga-Exendin-4 PET/CT Detects Insulinomas in Patients With Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.’, The Journal of clinical endocrinology and metabolism, 104(12), pp. 5843–5852. Available at: https://doi.org/10.1210/jc.2018-02754.

Dubach IL, Christ ER and Diem P (2019) ‘HbA(1c)-testing: Evaluation of two point-of-care analysers.’, Primary care diabetes, 13(6), pp. 583–587. Available at: https://doi.org/10.1016/j.pcd.2019.05.007.

von Niederhäusern PA et al. (2019) ‘Augmenting camera images with gamma detector data: A novel approach to support sentinel lymph node biopsy’, EJNMMI Physics, 6(1), p. 10. Available at: https://doi.org/10.1186/s40658-019-0245-z.

Zamboglou C et al. (2019) ‘Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.’, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 141, pp. 208–213. Available at: https://doi.org/10.1016/j.radonc.2019.07.002.

Buitinga M et al. (2019) ‘Succinylated gelatin improves the theranostic potential of radiolabeled exendin-4 in insulinoma patients’, Journal of Nuclear Medicine. 30.11.2018, 60(6), pp. 812–816. Available at: https://doi.org/10.2967/jnumed.118.219980.

Wolf KI et al. (2019) ‘Eruption of Metastatic Paraganglioma After Successful Therapy with (177)Lu/(90)Y-DOTATOC and (177)Lu-DOTATATE.’, 53(3). Available at: https://doi.org/10.1007/s13139-019-00579-w.

Antwi K et al. (2019) ‘Volume Replacement Fluid Demarks Benign Insulinoma With 68Ga-DOTA-Exendin-4 PET/CT.’, Clinical nuclear medicine, 44(5), pp. e347–e348. Available at: https://doi.org/10.1097/rlu.0000000000002522.

Aschwanden M et al. (2019) ‘Vessel wall plasticity in large vessel giant cell arteritis: An ultrasound follow-up study’, Rheumatology (United Kingdom), 58(5), pp. 792–797. Available at: https://doi.org/10.1093/rheumatology/key383.

Daly AF et al. (2019) ‘AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients.’, Endocrine connections, 8(4), pp. 367–377. Available at: https://doi.org/10.1530/ec-19-0004.

Kaderli RM et al. (2019) ‘Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.’, JAMA oncology, 5(4), pp. 480–489. Available at: https://doi.org/10.1001/jamaoncol.2018.6720.

Kwadwo A et al. (2019) ‘Erratum to: Molecular imaging for neuroendeocrine tumours.’, Swiss medical weekly, 149, p. w20076. Available at: https://doi.org/10.4414/smw.2019.20076.